glutathione pathway modulate cystic fibrosis severity SYNTHESIS Frontiers | Glutathione: Pharmacological aspects

After washing with TBST, the membranes were treated with secondary antibody (Proteintech) for 2 h at room temperature

Into the 2000s, links to diseases strengthened, with GPx4s tie to ferroptosis emerging as a breakthrough in cell death research

Also, two open-label trials using 400 mg/day of riboflavin have decreased migraine attack frequency from 4 attacks per month to 2 attacks per month, and from 8.7 attacks per month to 2.9 attacks per month, respectively (100)

doi: 10.1038/s41591-020-1003-4 [DOI] [PubMed] [Google Scholar] 62

This led the authors to conclude no difference between steroid treatment and placebo

D.DrckerP.HaenniD.PearsonA.GhaziS.et al (2020)